Core Viewpoint - The financing activities of Hong Kong New Drug (513780) indicate a trend of net selling in recent trading days, suggesting potential investor caution or profit-taking behavior [1] Financing Summary - On August 11, Hong Kong New Drug (513780) had a financing buy amount of 0.11 billion, ranking 1267th in the market, with a financing repayment amount of 0.14 billion, resulting in a net sell of 2.1273 million [1] - Over the last three trading days (August 7-11), the financing buy amounts were 0.21 billion, 0.18 billion, and 0.11 billion respectively, showing a declining trend in financing buy [1] Securities Lending Summary - On the same day, there were no shares sold or net sold in securities lending, indicating a lack of short-selling activity [1]